G361-0509 Screening compound: N-[3-(4-benzylpiperazin-1-yl)propyl]-2-{7-methyl-4-oxo-2-phenyl-4H,5H-pyrazolo[1,5-d][1,2,4]triazin-5-yl}acetamide

G361-0509 Screening compound: N-[3-(4-benzylpiperazin-1-yl)propyl]-2-{7-methyl-4-oxo-2-phenyl-4H,5H-pyrazolo[1,5-d][1,2,4]triazin-5-yl}acetamide
G361-0509 Screening compound: N-[3-(4-benzylpiperazin-1-yl)propyl]-2-{7-methyl-4-oxo-2-phenyl-4H,5H-pyrazolo[1,5-d][1,2,4]triazin-5-yl}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G361-0509
N-[3-(4-benzylpiperazin-1-yl)propyl]-2-{7-methyl-4-oxo-2-phenyl-4H,5H-pyrazolo[1,5-d][1,2,4]triazin-5-yl}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G361-0509

Molecular Formula

C28H33N7O2 (C28 H33 N7 O2)

Compound Name

N-[3-(4-benzylpiperazin-1-yl)propyl]-2-{7-methyl-4-oxo-2-phenyl-4H,5H-pyrazolo[1,5-d][1,2,4]triazin-5-yl}acetamide

IUPAC name

N-[3-(4-benzylpiperazin-1-yl)propyl]-2-{7-methyl-4-oxo-2-phenyl-4H5H-pyrazolo[15-d][124]triazin-5-yl}acetamide

SMILES

CC(n(c1c2)nc2-c2ccccc2)=NN(CC(NCCCN2CCN(Cc3ccccc3)CC2)=O)C1=O

InChI

InChI=1S/C28H33N7O2/c1-22-30-34(28(37)26-19-25(31-35(22)26)24-11-6-3-7-12-24)21-27(36)29-13-8-14-32-15-17-33(18-16-32)20-23-9-4-2-5-10-23/h2-7,9-12,19H,8,13-18,20-21H2,1H3,(H,29,36)

InChI Key

NDVQWHXMVFEIDC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15003222

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

499.62

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.193

Distribution Coefficient, logD

1.373

Water Solubility, LogSw

-2.84

Polar Surface Area

72.602

Acid Dissociation Constant (pKa)

16.02

Base Dissociation Constant (pKb)

8.15

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

35.70

G361-0509 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D

References: we are preparing a list of scientific research reports with G361-0509 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G361-0509?
Check Price and Availability of G361-0509, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G361-0509 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G361-0509
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G361-0509
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G361-0509 available by request